Doctors Gene-Edit Patient's Liver to Make Less Cholesterol
A team of researchers from US biotech company Verve Therapeutics have injected a gene-editing serum into a live patient's liver with the goal of lowering their cholesterol, a watershed moment in the history of gene editing that could potentially save millions from cardiovascular disease and heart attacks, MIT Technology Review reports.
https://futurism.com/neoscope/doctors-gene-edit-less-cholesterol
